K
Koninklijke Philips NV
F:PHI1
Koninklijke Philips NV
F:PHI1
Price:
27.02
EUR
0.63%
Market Closed
Market Cap:
€25.3B
Relative Value
There is not enough data to reliably calculate the relative value of PHI1.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PHI1
Relative Value
Base Case
Not Available
Multiples Across Competitors
PHI1 Competitors Multiples
Koninklijke Philips NV Competitors
Koninklijke Philips NV Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| NL |
K
|
Koninklijke Philips NV
F:PHI1
|
17.5B EUR | 1 | -21.8 | 25 | -63.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.2B USD | 4.4 | 29.9 | 16.9 | 23.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
170.7B USD | 16.9 | 59.7 | 45.3 | 55.7 | |
| US |
|
Stryker Corp
NYSE:SYK
|
140.4B USD | 5.6 | 43.3 | 21.9 | 26.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
129.8B USD | 3.7 | 27.3 | 15.3 | 22.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
109.9B USD | 5.5 | 37.9 | 22.6 | 30.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46B EUR | 2 | 21.6 | 12 | 16.9 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
49.9B USD | 11.5 | 46.9 | 33.5 | 37 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
51.2B USD | 2.3 | 30.5 | 11.6 | 19.7 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.5B USD | 7.6 | 32.6 | 23.1 | 25.3 | |
| US |
|
Resmed Inc
NYSE:RMD
|
36B USD | 6.7 | 24.3 | 17.1 | 19 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
